首页> 外文期刊>Oncology reports >Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
【24h】

Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.

机译:口腔鳞状细胞癌中尿激酶型纤溶酶原激活物/尿激酶型纤溶酶原激活物受体和maspin的表达:与侵袭方式和临床病理因素相关。

获取原文
获取原文并翻译 | 示例
       

摘要

It is well documented that the binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR), which has been implicated in cancer invasion and metastasis, is regulated by several inhibitors such as maspin. In this study, we investigated the interrelationship between clinicopathologic findings and expression of uPA, uPAR and maspin in oral squamous cell carcinoma (OSCC) to elucidate the participation of maspin in the uPA/uPAR system in the malignant behavior of OSCC. Using immunohistochemical techniques to examine the expression levels of uPA, uPAR and maspin in 54 cases of OSCC, we also compared the clinicopathologic features of OSCC with the expression levels of each. Moreover, we examined the expression of uPA, uPAR and maspin in six cell lines derived from OSCC using reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting. uPA and uPAR showed a positive correlation with the mode of cancer invasion; conversely maspin showed a negative correlation with the mode of invasion. Multivariate analysis revealed that only two factors (N-category and uPA+/uPAR+/maspin- expression pattern) were significant and independent variables with relative risks of 3.84 and 2.52, respectively. In particular, tumors exhibiting an expression pattern of uPA+/uPAR+/maspin- were highly malignant and were associated with the worst survival rate (5-year overall survival rate, 29.4%), while tumors with an expression pattern, uPA-/uPAR-/Muaspin+, showed the most favorable survival rate (5-year overall survival rate, 77.8%). In vitro, lower expression of maspin was also noted in the cell lines derived from grade 4D OSCC, which exhibited a stronger invasive potential than the cells lines derived from the other grades of OSCC, while uPA and uPAR demonstrated an expression trend opposite to maspin. These results indicate that uPA, uPAR and maspin expression patterns may be useful markers for evaluating the clinical course or prognosis of OSCC patients.
机译:众所周知,尿激酶型纤溶酶原激活剂(uPA)与其受体(uPAR)的结合已经与癌症的侵袭和转移有关,并受多种抑制剂(例如maspin)的调节。在这项研究中,我们调查了口腔鳞状细胞癌(OSCC)中uPA,uPA​​R和maspin的表达与临床病理结果之间的相互关系,以阐明maspin在uPA / uPAR系统中参与OSCC恶性行为。使用免疫组织化学技术检查54例OSCC中uPA,uPA​​R和maspin的表达水平,我们还将OSCC的临床病理特征与每种表达水平进行了比较。此外,我们使用逆转录聚合酶链反应(RT-PCR)和Western印迹检测了OSCC衍生的6种细胞系中uPA,uPA​​R和maspin的表达。 uPA和uPAR与癌的浸润方式呈正相关。相反,maspin与入侵方式呈负相关。多变量分析显示,只有两个因素(N-类别和uPA + / uPAR + / maspin表达模式)是显着且独立的变量,相对风险分别为3.84和2.52。特别是,表现出uPA + / uPAR + / maspin-表达模式的肿瘤是高度恶性的,并且与最差的生存率(5年总生存率29.4%)有关,而具有uPA- / uPAR- / uPAR-表达模式的肿瘤/ Muaspin +显示最有利的生存率(5年总生存率77.8%)。在体外,在4D OSCC级衍生的细胞系中也观察到了maspin的较低表达,与其他等级OSCC衍生的细胞系相比,其显示出更强的侵袭潜能,而uPA和uPAR则显示出与maspin相反的表达趋势。这些结果表明,uPA,uPA​​R和maspin表达模式可能是评估OSCC患者临床病程或预后的有用标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号